Enliven Therapeutics (ELVN) Non Operating Income (2019 - 2026)
Enliven Therapeutics (ELVN) reported Non Operating Income of $4.72 million for Q2 2026, up 45.4% from $3.25 million a year earlier and up 12.6% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Non Operating Income (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enliven Therapeutics' Non Operating Income came in at $18.49 million, up 31.8% year-over-year; for FY2025, it came in at $15.96 million, up 2.8% from FY2024.
- Non Operating Income has increased for three consecutive years, with a five-year compound annual growth rate of 116.2% (FY2020 to FY2025).
- By year, Non Operating Income came in at $15.53 million in FY2024 (+30.0%), $11.95 million in FY2023 (+958.0%), $1.13 million in FY2022 and $58,000 in FY2021 (-82.8%).
- Five-year quarterly Non Operating Income spans a low of $9,000 in Q1 2022 and a high of $4.95 million in Q3 2025.
- Year over year, Non Operating Income has now increased in each of the last four quarters, with growth averaging 14.9% over the last eight quarters.
- The high point for year-over-year Non Operating Income in five years was Q3 2023 (growth of 815.5%); the low point was Q3 2021 (a decline of 83.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.2 million (Q1 2026), $4.62 million (Q4 2025) and $4.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Enliven Therapeutics | 3.36 Bn | 3.36 Bn | - | 4.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.72 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | 4.62 Mn |
| Sep 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 3.25 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 4.65 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 3.41 Mn |
| Mar 31, 2023 | 1.69 Mn |
| Dec 31, 2022 | 613,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 127,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 12,000.00 |
API Access
Enliven Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();